Chemomab TherapeuticsCMMB

13F holders, Q1 2026 (March 31)
15holders +1
3new positions
3sold out
1famous investor
$1.57avg. 13F price*

At the end of Q1 2026, 15 institutions reported holding Chemomab Therapeutics Ltd. (CMMB) in their 13F filings, up 1 from Q4 2025. 3 opened new positions and 3 sold out. The largest holders were ADAR1 Capital Management, LLC ($126K), Citadel Advisors ($101K) and Kestra Private Wealth Services, LLC ($97K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Chemomab Therapeutics Ltd.
CUSIP
16385C203
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q3 2025: 10Q3 2025Q4 2025: 14Q4 2025Q1 2026: 15Q1 2026Q2 2026: 13Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions3$44K
Exits3$44K

All 13F filers, Q4 2025 → Q1 2026: 44,742 shares bought and 68,761 shares sold, net −24,019 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

ADAR1 Capital Management, LLC 0.01% No change 80,000 $126K
Citadel Advisors 0.00% Reduce -38.2% 64,182 $101K
Kestra Private Wealth Services, LLC 0.00% Add +19.3% 61,710 $97K
Ikarian Capital, LLC 0.01% No change 51,793 $81K
XTX Topco Ltd 0.00% Reduce -2.0% 18,629 $29K
Rhumbline Advisers 0.00% Add +2.9% 18,366 $29K
SmartHarvest Portfolios, LLC 0.01% New 14,566 $23K
Susquehanna International Group, LLP 0.00% New 13,491 $21K
BNP Paribas Financial Markets 0.00% Add +3.7% 8,425 $13K
Philadelphia Investment Partners, LLC 0.01% — 8,200 $13K
GAMMA Investing LLC 0.00% Add +201.5% 7,579 $12K
Morgan Stanley 0.00% Add +21.2% 4,575 $7K
SBI Securities Co., Ltd. 0.00% Add +7.7% 28 $44
UBS Group AG 0.00% Reduce -99.6% 8 $13
Caitong International Asset Management Co., Ltd 0.00% New 8 $13

"% of holder's portfolio" is CMMB's weight in each manager's 13F, not the share of Chemomab Therapeutics Ltd. the manager owns.